androstenedione has been researched along with Insulin Resistance in 119 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (8.40) | 18.7374 |
| 1990's | 23 (19.33) | 18.2507 |
| 2000's | 48 (40.34) | 29.6817 |
| 2010's | 31 (26.05) | 24.3611 |
| 2020's | 7 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, BS; Auchus, RJ; Brown, RJ; Jha, S; Merke, DP; Turcu, AF; Walzer, D | 1 |
| Fukuzawa, I; Hu, H; Jiao, P; Li, D; Li, R; Luo, L; Qiao, J; Shi, L; Wang, W; Zeng, L; Zhang, H; Zhao, J; Zhao, Y | 1 |
| Calvente Aguilar, V; Henríquez Linares, A; Lafuente González, P; López Verdú, H; Martínez García, MS; Pingarrón Santofímia, C; Poyo Torcal, S; Terol Sánchez, P | 1 |
| Abtahi, H; Behboudi-Gandevani, S; Ramezani Tehrani, F; Saadat, N; Tohidi, M | 1 |
| Basaki, M; Saeb, M; Saeb, S | 1 |
| Grymowicz, M; Kunicki, M; Machura, P; Rudnicka, E; Smolarczyk, R; Suchta, K | 1 |
| He, B; Li, C; Xing, C | 1 |
| Ghazanfarpour, M; Mirzaee, F; Najaf Najafi, M; Razmjouei, P; Shahrahmani, H; Vafisani, F | 1 |
| Gao, J; Li, X; Liu, X; Liu, Y; Zheng, W; Zuo, Y | 1 |
| Apa, R; De Cicco, S; Della Casa, S; Di Florio, C; Immediata, V; Lanzone, A; Policola, C; Romualdi, D; Scarinci, E; Tagliaferri, V; Tropea, A | 1 |
| Azadi-Yazdi, M; Fallahzadeh, H; Karimi-Zarchi, M; Nadjarzadeh, A; Salehi-Abargouei, A | 1 |
| Karadağ, C; Yavuz, DG; Yoldemir, T | 1 |
| Bolanowski, M; Kolačkov, K; Kuliczkowska-Plaksej, J; Mierzwicka, A | 1 |
| Avila, NA; El-Maouche, D; Hannah-Shmouni, F; Hargreaves, CJ; Mallappa, A; Merke, DP | 1 |
| Genazzani, AD; Marchini, F; Napolitano, A; Petrillo, T; Prati, A; Simoncini, T | 1 |
| Belfiore, A; D'Orrico, B; Fava, A; Fruci, B; Guzzi, P; Malaguarnera, R; Mazza, A; Veltri, P | 1 |
| da Silva Medeiros, MA; da Silva, AM; das Chagas Medeiros, F; de Andrade, AC; Dias, BH; Rao, VS | 1 |
| Cho, SJ; Gwak, HS; Ha, EH; Kim, HS; Kim, YJ; Lee, H; Lee, HA; Park, EA; Park, H | 1 |
| Arduç, A; Başaran, MN; Berker, D; Dağdelen, I; Doğan, BA; Güler, S; Küçükler, K; Tuna, MM | 1 |
| Baracat, EC; Consolim-Colombo, FM; Giribela, AH; Giribela, CR; Melo, NR; Moraes, TL; Nisenbaum, MG | 1 |
| Broekmans, FJ; Daan, NM; de Rijke, YB; Fauser, BC; Franco, OH; Jaspers, L; Kavousi, M; Koster, MP; Laven, JS | 1 |
| Bukan, N; Güneş, M | 1 |
| Absalón-Medina, VA; Butler, WR; Cheong, SH; Gilbert, RO; Pelton, SH; Sá Filho, OG | 1 |
| Aoki, K; Taguri, M; Tajima, K; Terauchi, Y | 1 |
| Codner, E; Devoto, L; Kohen, P; López, P; Rencoret, G; Salinas, A; Villarroel, C | 1 |
| Arlt, W; Jenkinson, C; Kempegowda, P; O'Reilly, MW; Quanson, JL; Storbeck, KH; Taylor, AE | 1 |
| Adaway, J; Keevil, B; Lerchbaum, E; Lindheim, L; Münzker, J; Obermayer-Pietsch, B; Pieber, TR; Trummer, C | 1 |
| Ambroziak, U; Bartoszewicz, Z; Bednarczuk, T; Dadlez, M; Jaźwiec, R; Kępczyńska-Nyk, A; Kondracka, A; Kuryłowicz, A; Samborowska, E; Wysłouch-Cieszyńska, A | 1 |
| Azziz, R; Berga, SL; Bittner, V; Braunstein, GD; Hodgson, TK; Johnson, BD; Merz, CN; Paul-Labrador, M; Shaw, L; Stanczyk, FZ | 1 |
| Asagami, T; Holmes, TH; Reaven, G | 1 |
| Benencia, HJ; Berg, GA; Boero, LE; Maidana, PN; Mesch, VR; Prada, M; Royer, M; Sayegh, F; Schreier, L; Siseles, NO | 1 |
| Baillargeon, JP; Ostlund, RE; Villeneuve, MC | 1 |
| Glueck, CJ; Morrison, JA; Wang, P | 1 |
| Arslan, M; Ayvaz, G; Cakir, N; Demirci, H; Ergün, MA; Ersoy, R; Karakoç, A; Yetkin, I; Yilmaz, M; Yurtçu, E | 1 |
| Cognigni, GE; Gambineri, A; Grassi, I; Pagotto, U; Pasquali, R; Pasqui, F; Patton, L; Pocognoli, P; Repaci, A | 1 |
| Adya, R; Chen, J; Farhatullah, S; Heutling, D; Kaur, J; Lehnert, H; Lewandowski, KC; O'Hare, JP; Randeva, HS; Tan, BK | 1 |
| Duskova, M; Hill, M; Starka, L | 1 |
| Li, W; Liu, YC; Wang, XX | 1 |
| Ballieux, BE; Dekker, FW; Euser, AM; Finken, MJ; Meuwese, CL; van Vliet, HA; Walther, FJ; Wit, JM | 1 |
| Cavazza, C; Ciampaglia, W; Cognigni, GE; Gambineri, A; Ibarra Gasparini, D; Pagotto, U; Pasquali, R | 1 |
| Bae, CS; Hou, L; Kuang, H; Stener-Victorin, E; Wang, Y; Wu, X; Yang, X; Zhang, Y | 1 |
| Costantino, D; Guaraldi, C; Minozzi, M; Unfer, V | 1 |
| Aldrighi, JM; Aoki, T; Kowastch, I; Mathias, W; Oliveira, RM; Ribeiro, AL; Scapinelli, A; Tamanaha, S | 1 |
| Birnie, E; Brown, ZA; de Jong, FH; Fauser, BC; Fong, SL; Laven, JS; Louwers, YV; Valkenburg, O | 1 |
| Hedberg, P; Herzig, KH; Morin-Papunen, L; Mutt, SJ; Nissinen, A; Piltonen, T; Puurunen, J; Ruokonen, A; Tapanainen, JS | 1 |
| Fujioka, K; Ikeda, T; Ishizuka, T; Kajita, K; Mori, I; Morita, H; Okada, H; Uno, Y | 1 |
| Li, M; Lin, Y; Ma, Y; Zheng, Z | 1 |
| Andrico, S; Falsetti, L; Gambera, A; Sartori, E | 1 |
| Blum, W; Eiholzer, U; Gasser, T; Girard, J; L'Allemand, D; Rousson, V; Torresani, T | 1 |
| Gambineri, A; Heiman, ML; Pagotto, U; Pasquali, R; Tschöp, M; Vicennati, V | 1 |
| Biciková, M; Dvoráková, K; Hill, M; Stárka, L; Tallová, J; Vrbíková, J | 1 |
| Bayraktar, M; Oguz, H; Yarali, H; Yildiz, BO | 1 |
| Ciampelli, M; Giuliani, M; Guido, M; Lanzone, A; Leoni, F; Perri, C; Romualdi, D | 1 |
| Azziz, R; Bartolucci, AA; Farah-Eways, L; Knochenhauer, ES; Reyna, R | 1 |
| Hirasing, RA; Kaptein, MB; Koppenaal, C; Schoemaker, J; van Hooff, MH; Voorhorst, FJ | 1 |
| Apa, R; Costantini, B; Giuliani, M; Guido, M; Lanzone, A; Romualdi, D; Suriano, R | 1 |
| Kasa-Vubu, JZ; Lee, CC; Supiano, MA | 1 |
| Dvoráková, K; Hill, M; Stanická, S; Stárka, L; Vondra, K; Vrbíková, J | 1 |
| Cacciari, M; Gambineri, A; Manicardi, E; Morselli-Labate, AM; Pagotto, U; Pasquali, R; Pelusi, C; Vicennati, V | 1 |
| Fleming, R; Harborne, LR; Norman, JE; Sattar, N | 1 |
| Liu, Y; Lv, L; Sun, Y; Tan, K | 1 |
| González, F; Kirwan, JP; Minium, J; Rote, NS | 2 |
| Cikim, AS; Molvalilar, S; Orhan, Y; Ozbey, N; Sencer, E | 1 |
| Kantarci, M; Karaca, L; Koçak, N; Orbak, Z; Tan, H | 1 |
| Al-Shoumer, KA; Al-Zaid, M; Doi, SA; Scott, CJ; Towers, PA | 1 |
| Andres, J; Bähr, V; Bobbert, T; Diederich, S; Kullmann, V; Mai, K; Möhlig, M; Osterhoff, M; Pfeiffer, AF; Rochlitz, H; Spranger, J; Weickert, MO | 1 |
| Hahn, S; Haselhorst, U; Janssen, OE; Kimmig, R; Mann, K; Quadbeck, B; Tan, S | 1 |
| Bjekic, J; Damjanovic, S; Farmakiotis, D; Katsikis, I; Kourtis, A; Macut, D; Panidis, D; Petakov, M; Rousso, D; Spanos, N | 1 |
| Arslan, M; Cakir, N; Ergün, MA; Karakoç, A; Yilmaz, M; Yurtçu, E | 1 |
| Amato, MC; Criscimanna, A; Galluzzo, A; Giordano, C; Mattina, A; Merlino, S; Richiusa, P | 1 |
| Baba, T; Endo, T; Hayashi, T; Honnma, H; Ikeda, H; Kamiya, H; Kitajima, Y; Masumori, N; Moriwaka, O; Saito, T | 1 |
| Azziz, R; Klein, M; Kumar, A; Spencer, JB | 1 |
| Farmakiotis, D; Katsikis, I; Kourtis, A; Krassas, G; Panidis, D; Rousso, D | 1 |
| Chang, RJ; Judd, HL; Kaplan, SA; Nakamura, RM | 1 |
| Barbieri, RL; Makris, A; Ryan, KJ | 1 |
| Bano, G; Kent, A; Lacey, JH; Nussey, SS; Peattie, A; Raphael, FJ; Rodin, DA | 1 |
| de Moura, MD; dos Reis, RM; Ferriani, RA; Foss, MC; Silva de Sá, MF | 1 |
| Barini, A; Dell'Acqua, S; Liberale, I; Lucisano, A; Martino, G; Menini, E; Tropeano, G; Vuolo, IP | 1 |
| Cantobelli, S; Casimirri, F; Labate, AM; Paradisi, R; Pasquali, R; Venturoli, S; Zannarini, L | 1 |
| Delson, R; Dunaif, A; Green, G; Sorbara, L | 1 |
| Deshwal, N; Lehman, L; Rittmaster, RS | 1 |
| Anttila, L; Erkkola, R; Irjala, K; Jaatinen, TA; Koskinen, P; Ruutiainen, K | 1 |
| Beer, NA; Beer, RM; Jakubowicz, DJ; Nestler, JE | 1 |
| Cucinotta, D; Denuzzo, G; Frisina, N; Gigante, A; Lasco, A; Pedulla, M; Trifiletti, A | 1 |
| Açbay, O; Gündoğdu, S | 1 |
| Anttila, L; Irjala, K; Penttilä, T; Rouru, J | 1 |
| Falcone, T; Morris, DV | 1 |
| Bergiele, A; Diamanti-Kandarakis, E; Kouli, C; Tsianateli, T | 1 |
| Bayram, F; Keleştimur, F; Sahin, Y; Unlühizarci, K | 1 |
| Aoki, K; Kaneshiro, M; Kawasaki, S; Mukasa, K; Okamura, A; Saito, T; Satoh, S; Sekihara, H | 1 |
| Acién, M; Acién, P; Alfayate, R; López-Fernández, JA; Matallín, P; Mauri, M; Quereda, F; Villarroya, E | 1 |
| Bayram, F; Keleştimur, F; Sahin, Y; Tutuş, A; Unlühizarci, K | 1 |
| Chevenne, D; Czernichow, P; Jaquet, D; Leger, J; Levy-Marchal, C | 1 |
| Ben-Chetrit, A; Greenblatt, EM; Lemieux, S; Lewis, GF; Steiner, G | 1 |
| Marsden, PJ; Murdoch, AP; Taylor, R | 1 |
| Bailey, MT; Christman, SA; Head, WA; Wheaton, JE | 1 |
| Abyholm, T; Dale, PO; Fedorcsák, P; Storeng, R; Tanbo, T | 2 |
| Calvo, RM; Escobar-Morreale, HF; San Millán, JL; Sancho, J; Villuendas, G | 1 |
| Fujisawa, T; Hachiya, M; Hachiya, Y; Hoshino, K; Saji, T; Satoh, M; Yokoya, S | 1 |
| Dökmetaş, HS; Erselcan, T; Sencan, M; Topcu, S; Yüksel, O | 1 |
| Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A; Tapanainen, JS | 1 |
| Demant, T; Halser, B; Strowitzki, T | 1 |
| Calvo, RM; Escobar-Morreale, HF; San Millán, JL; Sancho, J; Tellería, D | 1 |
| Durmusoglu, F; Elter, K; Imir, G | 1 |
| Cabrol, S; Chevenne, D; Czernichow, P; Léger, J; Lévy-Marchal, C; Meas, T; Thibaud, E | 1 |
| Bar, RS; Dawood, Y; Imperato-McGinley, J; Peterson, RE; Sturla, E | 1 |
| Abyholm, T; Dale, PO; Tanbo, T; Vaaler, S | 1 |
| Blackard, WG; Clore, JN; Matt, DW; Nestler, JE; Plymate, SR; Powers, LP; Rittmaster, RS; Steingold, KA | 1 |
| Mizuno, M; Taketani, Y | 1 |
| Falcone, T; Fantus, IG; Finegood, DT; Morris, D | 1 |
| Cavallo, A; Meyer, WJ; Peters, EJ; Prince, MJ; Richards, GE; Smith, ER; Stuart, CA | 1 |
| Jialal, I; Joubert, SM; Moodley, J; Naiker, P; Reddi, K | 1 |
| Friedman, CI; Kim, MH; Richards, S | 1 |
| Billiar, RB; Little, B; Posner, B; Richardson, D; Schwartz, R | 1 |
| Baird, D; Benton, C; Clarke, BF; Collier, A; Doig, A; Kellett, HA; Sawers, JS; Taylor, R | 1 |
| Kelver, ME; Nagamani, M; Van Dinh, T | 1 |
| Meyer, WJ; Peters, EJ; Prince, MJ; Stuart, CA | 1 |
2 review(s) available for androstenedione and Insulin Resistance
| Article | Year |
|---|---|
Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
Topics: Adult; Androstenedione; Blood Glucose; Female; Glucagon-Like Peptide-1 Receptor; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Menstruation; Metabolome; Metformin; Network Meta-Analysis; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Sex Hormone-Binding Globulin; Testosterone; Thiazolidinediones | 2020 |
The effect and safety of Berberine on polycystic ovary syndrome: a systematic review.
Topics: Adult; Androstenedione; Berberine; Body Mass Index; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Polycystic Ovary Syndrome; Treatment Outcome; Waist Circumference; Waist-Hip Ratio | 2021 |
21 trial(s) available for androstenedione and Insulin Resistance
| Article | Year |
|---|---|
Evaluation of the efficacy of an antioxidant combination for the modulation of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndrome.
Topics: Androstenedione; Antioxidants; Contraceptives, Oral; Dietary Supplements; Female; Humans; Insulin Resistance; Menstruation Disturbances; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life | 2023 |
Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral; Cyproterone Acetate; Female; Humans; Insulin; Insulin Resistance; Phlebotomy; Polycystic Ovary Syndrome; Testosterone; Triglycerides; Young Adult | 2019 |
Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
Topics: Adult; Androgens; Androstenedione; Antioxidants; Biomarkers; Blood Glucose; Body Composition; Body Mass Index; Dietary Approaches To Stop Hypertension; Female; Humans; Insulin; Insulin Resistance; Obesity; Overweight; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Weight Loss; Young Adult | 2017 |
Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adult; Androstenedione; Cohort Studies; Comorbidity; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Male; Maryland; Obesity; Tertiary Care Centers; Tomography, X-Ray Computed; Young Adult | 2019 |
In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone.
Topics: Adult; Androstenedione; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Female; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Spironolactone; Testosterone; Young Adult | 2014 |
Insulin and metformin regulate circulating and adipose tissue chemerin.
Topics: Adipose Tissue; Adolescent; Adult; Androstenedione; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Estradiol; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Omentum; Organ Culture Techniques; Polycystic Ovary Syndrome; Receptors, Chemokine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone; Up-Regulation; Young Adult | 2009 |
The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Cholesterol; Cholesterol, LDL; Contraceptives, Oral, Combined; Female; Humans; Inositol; Insulin Resistance; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Treatment Outcome; Triglycerides; Vitamin B Complex | 2011 |
Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study.
Topics: 17-alpha-Hydroxyprogesterone; Administration, Cutaneous; Administration, Intravaginal; Adult; Androgens; Androstenedione; Biomarkers; Blood Glucose; C-Peptide; C-Reactive Protein; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Lipoproteins; Sex Hormone-Binding Globulin; Testosterone | 2012 |
Effect of royal jelly ingestion for six months on healthy volunteers.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Dehydroepiandrosterone Sulfate; Dietary Supplements; Double-Blind Method; Erythropoiesis; Fatty Acids; Female; Hematinics; Humans; Insulin Resistance; Intention to Treat Analysis; Japan; Male; Mental Health; Middle Aged; Psychiatric Status Rating Scales; Time Factors | 2012 |
[Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].
Topics: Administration, Oral; Adult; Androstenedione; Blood Glucose; Body Weight; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Lipids; Luteinizing Hormone; Menstruation; Neuropeptide Y; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2002 |
Increased adrenal androgen levels in patients with Prader-Willi syndrome are associated with insulin, IGF-I, and leptin, but not with measures of obesity.
Topics: Adolescent; Adrenal Glands; Analysis of Variance; Androgens; Androstenedione; Anthropometry; Body Composition; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Growth Hormone; Hormone Replacement Therapy; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Leptin; Male; Obesity; Prader-Willi Syndrome; Prospective Studies; Puberty, Precocious | 2002 |
Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.
Topics: Adult; Androgens; Androstenedione; Diet, Reducing; Female; Ghrelin; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Peptide Hormones; Polycystic Ovary Syndrome | 2002 |
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Androgens; Androstenedione; Body Constitution; Body Mass Index; Female; Follicle Stimulating Hormone; Glucose Clamp Technique; Glucose Tolerance Test; Hirsutism; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Luteinizing Hormone; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Thiazolidinediones | 2003 |
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Androstenedione; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glucose Tolerance Test; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Thiazolidinediones | 2004 |
Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.
Topics: Administration, Oral; Androstenedione; Blood Glucose; Dehydroepiandrosterone Sulfate; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Weight Loss | 2005 |
Effects of metformin combined with cyproterone acetate on clinical features, endocrine and metabolism of non-obese women with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Body Mass Index; Cyproterone Acetate; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome | 2005 |
Free fatty acids increase androgen precursors in vivo.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adult; Androgens; Androstenedione; Blood Glucose; Cross-Over Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fatty Acids, Nonesterified; Glucose Clamp Technique; Humans; Insulin Resistance; Lipids; Male; Stimulation, Chemical | 2006 |
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Anti-Obesity Agents; Blood Glucose; Body Mass Index; Caloric Restriction; Case-Control Studies; Combined Modality Therapy; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Lactones; Luteinizing Hormone; Obesity; Orlistat; Polycystic Ovary Syndrome; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Weight Loss | 2008 |
The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men.
Topics: Adult; Amlodipine; Androgens; Androstenedione; Calcium Channel Blockers; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fasting; Glucose Tolerance Test; Humans; Hydrocortisone; Hypertension; Insulin Resistance; Male; Middle Aged; Obesity | 1993 |
Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Blood Glucose; Female; Glucose Clamp Technique; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1998 |
Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study.
Topics: Adolescent; Adult; Androstenedione; Body Constitution; Body Mass Index; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin | 2002 |
96 other study(ies) available for androstenedione and Insulin Resistance
| Article | Year |
|---|---|
Excess 11-Oxygenated Androgens in Women With Severe Insulin Resistance Are Mediated by Adrenal Insulin Receptor Signaling.
Topics: Androgens; Androstenedione; Antigens, CD; Chromatography, Liquid; Cross-Sectional Studies; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipodystrophy; Polycystic Ovary Syndrome; Receptor, Insulin; Steroid 11-beta-Hydroxylase; Steroids; Tandem Mass Spectrometry; Testosterone | 2022 |
Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
Topics: Androstenedione; Blood Glucose; Body Composition; Cross-Sectional Studies; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Insulin Resistance; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Testosterone | 2022 |
Androgen profile in young females with insulin resistance; the importance of 17-Hydroxyprogesterone
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Androstenedione; Blood Glucose; Case-Control Studies; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Insulin; Insulin Resistance; Testosterone; Young Adult | 2019 |
Inflammatory Markers in Women with Polycystic Ovary Syndrome.
Topics: Adolescent; Adult; Androgens; Androstenedione; Biomarkers; Body Mass Index; C-Reactive Protein; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Leukocytes; Obesity; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2020 |
The risk factors of gestational diabetes mellitus in patients with polycystic ovary syndrome: What should we care.
Topics: Adult; Age Factors; Androstenedione; Body Mass Index; China; Diabetes, Gestational; Fasting; Female; Fetal Membranes, Premature Rupture; Humans; Incidence; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Polyhydramnios; Postpartum Hemorrhage; Pre-Eclampsia; Pregnancy; Premature Birth; Risk Factors; Sex Hormone-Binding Globulin; Testosterone; Young Adult | 2021 |
Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action.
Topics: Adolescent; Adult; Androstenedione; Body Mass Index; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Female; Humans; Inositol; Insulin Resistance; Organ Size; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Thioctic Acid; Young Adult | 2017 |
Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
Topics: Adolescent; Adult; Androstenedione; Blood Glucose; Body Mass Index; Cholecalciferol; Dietary Supplements; Female; Humans; Insulin Resistance; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Vitamin D; Vitamin D Deficiency; Young Adult | 2018 |
Preptin in women with polycystic ovary syndrome.
Topics: Absorptiometry, Photon; Adolescent; Adult; Androstenedione; Biomarkers; Blood Glucose; Body Composition; Body Mass Index; Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor II; Luteinizing Hormone; Middle Aged; Peptide Fragments; Polycystic Ovary Syndrome; Testosterone; Waist Circumference; Young Adult | 2018 |
Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both.
Topics: Adult; Androstenedione; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Inositol; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Overweight; Polycystic Ovary Syndrome; Retrospective Studies; Testosterone; Thioctic Acid; Treatment Outcome; Vitamin B Complex; Young Adult | 2019 |
Elevated diastolic blood pressure in insulin-resistant polycystic ovarian syndrome patients.
Topics: Adult; Androstenedione; Blood Glucose; Blood Pressure; Body Mass Index; Case-Control Studies; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies | 2014 |
Effect of urinary bisphenolA on androgenic hormones and insulin resistance in preadolescent girls: a pilot study from the Ewha Birth & Growth Cohort.
Topics: Androgens; Androstenedione; Benzhydryl Compounds; Body Mass Index; Child; Chromatography, High Pressure Liquid; Cohort Studies; Female; Follow-Up Studies; Humans; Immunoassay; Insulin; Insulin Resistance; Phenols; Republic of Korea; Testosterone | 2013 |
Increased Risk of Unfavorable Metabolic Outcome in Patients with Clinically Nonfunctioning Pituitary Adenomas.
Topics: Adenoma; Adult; Androstenedione; Atherosclerosis; Female; Humans; Hyperandrogenism; Insulin Resistance; Middle Aged; Pituitary Neoplasms; Risk | 2015 |
Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
Topics: Adult; Aldosterone; Androstenedione; Androstenes; Blood Pressure; Body Mass Index; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Insulin Resistance; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System; Testosterone; Triglycerides | 2015 |
Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Topics: Adult; Androgens; Androstenedione; Body Mass Index; Cardiovascular Diseases; Chromatography, Liquid; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Endocrine System; Female; Humans; Insulin Resistance; Middle Aged; Multivariate Analysis; Polycystic Ovary Syndrome; Postmenopause; Primary Ovarian Insufficiency; Steroids; Tandem Mass Spectrometry; Testosterone; Young Adult | 2015 |
Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome.
Topics: Adult; Androstenedione; Angiopoietin-Like Protein 4; Angiopoietins; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Cytokines; Dehydroepiandrosterone Sulfate; Estradiol; Female; GPI-Linked Proteins; Humans; Insulin Resistance; Lectins; Luteinizing Hormone; Neuropeptide Y; Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 2015 |
Metabolic and Endocrine Differences Between Dairy Cows That Do or Do Not Ovulate First Postpartum Dominant Follicles.
Topics: Androstenedione; Animals; Carbohydrate Metabolism; Cattle; Energy Metabolism; Estradiol; Female; Fertility; Follicular Fluid; Glucose Tolerance Test; Insulin Resistance; Luteinizing Hormone; Ovarian Follicle; Ovulation; Postpartum Period; Proteins; Theca Cells | 2016 |
Effect of dehydroepiandrosterone (DHEA) on Akt and protein kinase C zeta (PKCζ) phosphorylation in different tissues of C57BL6, insulin receptor substrate (IRS)1(-/-), and IRS2(-/-) male mice fed a high-fat diet.
Topics: Androstenedione; Animals; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Diet, High-Fat; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Organ Specificity; Protein Kinase C; Proto-Oncogene Proteins c-akt | 2016 |
Pregestational type 2 diabetes and gestational diabetes exhibit different sexual steroid profiles during pregnancy.
Topics: Adult; Androstenedione; Chile; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Diabetes, Gestational; Down-Regulation; Estradiol; Estriol; Estrone; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Longitudinal Studies; Pregnancy; Pregnancy in Diabetics; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Tertiary Care Centers | 2017 |
11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
Topics: Adult; Androgens; Androstenedione; Androstenes; Blood Glucose; Case-Control Studies; Chromatography, Liquid; Dehydroepiandrosterone; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxytestosterones; Hyperandrogenism; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Tandem Mass Spectrometry; Testosterone; Young Adult | 2017 |
High salivary testosterone-to-androstenedione ratio and adverse metabolic phenotypes in women with polycystic ovary syndrome.
Topics: Adult; Androstenedione; Anovulation; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Glucose Intolerance; Humans; Insulin Resistance; Metabolic Diseases; Metabolic Syndrome; Phenotype; Polycystic Ovary Syndrome; Saliva; Tandem Mass Spectrometry; Testosterone | 2017 |
Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
Topics: Adipose Tissue; Adolescent; Adult; Androstenedione; Body Composition; Body Mass Index; Case-Control Studies; Chromatography, Liquid; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Prognosis; Tandem Mass Spectrometry; Testosterone; Waist Circumference; Young Adult | 2017 |
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.
Topics: Adult; Aged; Aged, 80 and over; Androgens; Androstenedione; Body Mass Index; Chest Pain; Coronary Angiography; Cross-Sectional Studies; Estradiol; Estrogens; Estrone; Female; Humans; Insulin Resistance; Middle Aged; Myocardial Ischemia; Postmenopause; Sex Hormone-Binding Globulin; Testosterone | 2008 |
Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.
Topics: Adult; Androstenedione; Blood Glucose; Female; Humans; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Testosterone | 2008 |
Androgens in relationship to cardiovascular risk factors in the menopausal transition.
Topics: Abdominal Fat; Adult; Age Factors; Aged; Androgens; Androstenedione; Argentina; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Dehydroepiandrosterone Sulfate; Estradiol; Female; Humans; Insulin Resistance; Lipoproteins; Menopause; Middle Aged; Risk Factors; Triglycerides | 2008 |
Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity.
Topics: 17-alpha-Hydroxypregnenolone; Adolescent; Adult; Androstenedione; Blood Glucose; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Female; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperinsulinism; Inositol; Insulin Resistance; Male; Pilot Projects; Sex Hormone-Binding Globulin; Testosterone; Young Adult | 2009 |
Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome.
Topics: Adolescent; Androstenedione; Blood Coagulation Disorders, Inherited; Child; Coronary Disease; Family Health; Female; Fibrinolysis; Genetic Predisposition to Disease; Humans; Hyperandrogenism; Insulin Resistance; Obesity; Plasminogen Inactivators; Polycystic Ovary Syndrome; Puberty, Precocious; Risk Factors | 2008 |
Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome.
Topics: Adult; Androstenedione; Blood Glucose; Calpain; Dehydroepiandrosterone Sulfate; Female; Humans; Insulin Resistance; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Testosterone | 2009 |
Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Biomarkers; Case-Control Studies; Cholesterol, HDL; Dehydroepiandrosterone Sulfate; Down-Regulation; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin; Insulin Resistance; Italy; Logistic Models; Metabolic Syndrome; Middle Aged; Polycystic Ovary Syndrome; Prevalence; Risk Assessment; Risk Factors; Testosterone; White People; Young Adult | 2009 |
Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Alopecia; Androstenedione; Biomarkers; Blood Glucose; Enzyme Inhibitors; Finasteride; Glycated Hemoglobin; Humans; Insulin Resistance; Lipids; Male; Severity of Illness Index; Testosterone; Time Factors; Treatment Outcome | 2010 |
[Controlling effect of berberine on in vitro synthesis and metabolism of steroid hormones in insulin resistant ovary].
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Animals; Berberine; Female; In Vitro Techniques; Insulin; Insulin Resistance; Mice; Mice, Inbred Strains; Ovary; Polycystic Ovary Syndrome; Progesterone; Testosterone | 2010 |
Growth-restricted preterm newborns are predisposed to functional adrenal hyperandrogenism in adult life.
Topics: Adolescent; Adrenal Gland Diseases; Adult; Androstenedione; Birth Weight; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Female; Fetal Growth Retardation; Gestational Age; Humans; Hydrocortisone; Hyperandrogenism; Immunoassay; Infant, Newborn; Insulin; Insulin Resistance; Male; Pregnancy; Regression Analysis; Young Adult | 2010 |
Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome.
Topics: Adult; Aged; Androstenedione; Female; Follow-Up Studies; Humans; Insulin Resistance; Intra-Abdominal Fat; Logistic Models; Middle Aged; Obesity; Polycystic Ovary Syndrome; Predictive Value of Tests; Risk Reduction Behavior; Weight Loss | 2011 |
Cryptotanshinone reverses reproductive and metabolic disturbances in prenatally androgenized rats via regulation of ovarian signaling mechanisms and androgen synthesis.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Animals; Drugs, Chinese Herbal; Female; Glucose; Insulin; Insulin Resistance; Models, Animal; Ovary; Phenanthrenes; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reproduction; Signal Transduction; Testosterone | 2011 |
Myeloperoxidases and polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Biomarkers; Body Mass Index; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Peroxidase; Polycystic Ovary Syndrome; Young Adult | 2012 |
The phenotype of polycystic ovary syndrome ameliorates with aging.
Topics: Adult; Age Factors; Aging; Androstenedione; Biomarkers; Blood Glucose; Chi-Square Distribution; Dehydroepiandrosterone Sulfate; Female; Follow-Up Studies; Humans; Insulin; Insulin Resistance; Menstrual Cycle; Netherlands; Ovary; Phenotype; Polycystic Ovary Syndrome; Retrospective Studies; Testosterone; Young Adult | 2011 |
Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Amenorrhea; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Hirsutism; Humans; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Luteinizing Hormone; Obesity; Oligomenorrhea; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography | 2002 |
Plasma thiols and androgen levels in polycystic ovary syndrome.
Topics: Adolescent; Adult; Age Factors; Androgens; Androstenedione; Case-Control Studies; Cholesterol; Cholesterol, HDL; Dehydroepiandrosterone Sulfate; Estradiol; Female; Glutathione; Homocysteine; Humans; Hyperlipidemias; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Regression Analysis; Sex Hormone-Binding Globulin; Sulfhydryl Compounds; Testosterone | 2003 |
Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Topics: Adult; Androstenedione; Body Constitution; Body Mass Index; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Female; Follicle Stimulating Hormone; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Luteinizing Hormone; Male; Menopause; Middle Aged; Mothers; Polycystic Ovary Syndrome; Siblings; Testosterone | 2003 |
Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Androstenedione; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Glucose; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin Resistance; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2004 |
Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years.
Topics: Adolescent; Amenorrhea; Androstenedione; Blood Glucose; Body Mass Index; Female; Hormones; Humans; Insulin; Insulin Resistance; Logistic Models; Luteinizing Hormone; Menstrual Cycle; Odds Ratio; Oligomenorrhea; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 2004 |
Androgenicity and obesity are independently associated with insulin sensitivity in postmenopausal women.
Topics: Aged; Aged, 80 and over; Androgens; Androstenedione; Body Composition; Body Constitution; Dehydroepiandrosterone Sulfate; Female; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Postmenopause; Regression Analysis; Testosterone | 2004 |
Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome.
Topics: 17-Hydroxysteroid Dehydrogenases; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgen Antagonists; Androgens; Androstenedione; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipids; Obesity; Polycystic Ovary Syndrome; Steroids; Testosterone | 2004 |
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.
Topics: Adolescent; Adult; Androstenedione; Blood Glucose; Cohort Studies; Cosyntropin; Diabetes Mellitus; Diabetes Mellitus, Type 2; Family Health; Feeding Behavior; Female; Glucose Intolerance; Humans; Hydrocortisone; Insulin; Insulin Resistance; Mediterranean Region; Obesity; Phenotype; Physical Fitness; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 2004 |
Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Area Under Curve; Body Composition; Body Weight; Female; Glucose; Humans; Hyperandrogenism; Hyperglycemia; Insulin Resistance; Lipid Peroxidation; Monocytes; NADPH Oxidases; Obesity; Oxidative Stress; Phosphoproteins; Polycystic Ovary Syndrome; Reactive Oxygen Species; Testosterone; Thiobarbituric Acid Reactive Substances; Waist-Hip Ratio | 2006 |
Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women.
Topics: Adult; Age Factors; Androstenedione; Blood Glucose; Blood Pressure; Body Mass Index; Case-Control Studies; Cholesterol, HDL; Female; Humans; Insulin; Insulin Resistance; Metabolic Syndrome; Obesity; Premenopause; Regression Analysis; Sex Hormone-Binding Globulin; Testosterone; Triglycerides; Uric Acid; Waist-Hip Ratio | 2004 |
Valproate-induced insulin resistance in prepubertal girls with epilepsy.
Topics: Adolescent; Androstenedione; Anticonvulsants; Blood Glucose; Body Mass Index; Child; Cross-Sectional Studies; Epilepsy; Female; Humans; Insulin; Insulin Resistance; Lipids; Ovary; Prolactin; Puberty; Testosterone; Ultrasonography; Valproic Acid | 2005 |
Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Estradiol; Female; Follicle Stimulating Hormone; Homeostasis; Humans; Hypothalamus; Insulin; Insulin Resistance; Luteinizing Hormone; Neurosecretory Systems; Obesity; Pituitary Gland; Polycystic Ovary Syndrome; Regression Analysis; Testosterone | 2005 |
Decreased soluble leptin receptor levels in women with polycystic ovary syndrome.
Topics: Adult; Androstenedione; Blood Glucose; Body Composition; Body Mass Index; Cholesterol; Estradiol; Female; Humans; Hydrocortisone; Insulin Resistance; Insulin-Like Growth Factor I; Leptin; Obesity; Polycystic Ovary Syndrome; Receptors, Cell Surface; Receptors, Leptin; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Thyrotropin | 2006 |
Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome.
Topics: Adolescent; Adult; Analysis of Variance; Androstenedione; Area Under Curve; Biomarkers; Blood Glucose; Body Mass Index; Female; Hormones; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Obesity; Overweight; Polycystic Ovary Syndrome; Pregnancy; Proinsulin; Sex Hormone-Binding Globulin; Steroid 17-alpha-Hydroxylase; Testosterone | 2006 |
Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Biotransformation; Blood Glucose; Body Composition; Body Mass Index; Female; Glucose; Glucose Tolerance Test; Humans; Hyperglycemia; I-kappa B Proteins; Inflammation; Insulin Resistance; Monocytes; NF-kappa B; Obesity; Oncogene Protein p65(gag-jun); Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Waist-Hip Ratio | 2006 |
Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
Topics: Adult; Alanine; Androstenedione; Blood Glucose; C-Peptide; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Heterozygote; Homeostasis; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Polycystic Ovary Syndrome; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; PPAR gamma; Proline; Testosterone | 2006 |
Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Dehydroepiandrosterone Sulfate; Diagnosis, Differential; Female; Hirsutism; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Metabolic Syndrome; Obesity; Polycystic Ovary Syndrome; Sicily; Testosterone | 2006 |
Association between polycystic ovary syndrome and female-to-male transsexuality.
Topics: Adiponectin; Adolescent; Adult; Androgens; Androstenedione; Female; Gender Identity; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Polycystic Ovary Syndrome; Testosterone; Transsexualism | 2007 |
The age-associated decline of androgens in reproductive age and menopausal Black and White women.
Topics: Adolescent; Adult; Aging; Androgens; Androstenedione; Black People; Body Mass Index; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Female; Humans; Insulin Resistance; Menopause; Middle Aged; Sex Hormone-Binding Globulin; Testosterone; Waist-Hip Ratio; White People | 2007 |
Insulin resistance in nonobese patients with polycystic ovarian disease.
Topics: Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Glucose; Humans; Insulin; Insulin Resistance; Kinetics; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1983 |
Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca.
Topics: Acanthosis Nigricans; Adult; Androgens; Androstenedione; Dihydrotestosterone; Female; Humans; Hyperinsulinism; In Vitro Techniques; Insulin; Insulin Resistance; Luteinizing Hormone; Ovary; Stimulation, Chemical; Syndrome; Testosterone; Theca Cells; Time Factors | 1984 |
Ovarian morphology and insulin sensitivity in women with bulimia nervosa.
Topics: Adult; Androstenedione; Blood Glucose; Bulimia; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Male; Ovary; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography | 1995 |
Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism.
Topics: Adolescent; Adult; Androstenedione; Blood Glucose; Female; Glucose Tolerance Test; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Insulin Secretion; Obesity; Polycystic Ovary Syndrome; Testosterone | 1995 |
Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Androgens; Androstenedione; beta-Endorphin; C-Peptide; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Radioimmunoassay; Testosterone | 1994 |
Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism.
Topics: Abdomen; Adipose Tissue; Adolescent; Adult; Androgens; Androstenedione; Blood Glucose; Body Constitution; Body Weight; Estrogens; Female; Gonadal Steroid Hormones; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Luteinizing Hormone; Middle Aged; Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1993 |
Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women.
Topics: Adolescent; Adult; Analysis of Variance; Androstenedione; Blood Glucose; Body Composition; Body Weight; Dominican Republic; Female; Glucose Tolerance Test; Hispanic or Latino; Humans; Insulin; Insulin Resistance; Lipids; Metabolic Clearance Rate; Polycystic Ovary Syndrome; Puerto Rico; Sex Hormone-Binding Globulin; Testosterone; United States | 1993 |
The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.
Topics: Adrenal Gland Diseases; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Androstenedione; Female; Glucose; Hirsutism; Humans; Insulin Resistance; Menstrual Cycle; Obesity; Polycystic Ovary Syndrome | 1993 |
Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease.
Topics: Adolescent; Adult; Androgens; Androstenedione; Blood Glucose; C-Peptide; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 1993 |
No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide.
Topics: Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Glucose Clamp Technique; Gonadotropin-Releasing Hormone; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Leuprolide; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Testosterone | 1995 |
Can metformin reduce insulin resistance in polycystic ovary syndrome?
Topics: Adult; Androstenedione; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fasting; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Luteinizing Hormone; Metformin; Placebos; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 1996 |
Normal serum uric acid concentrations in women with polycystic ovary syndrome.
Topics: Adult; Androstenedione; Body Mass Index; Female; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Polycystic Ovary Syndrome; Reference Values; Sex Hormone-Binding Globulin; Testosterone; Triglycerides; Uric Acid | 1996 |
The relationship between insulin sensitivity and insulin-like growth factor-binding protein-1.
Topics: Androstenedione; Body Mass Index; Case-Control Studies; Female; Glucose Tolerance Test; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Polycystic Ovary Syndrome; Testosterone | 1996 |
The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Blood Glucose; Cytochrome P-450 Enzyme System; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Isoenzymes; Metformin; Polycystic Ovary Syndrome | 1999 |
Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone.
Topics: Androstenedione; Animals; Blood Glucose; Body Composition; Chromans; Dehydroepiandrosterone; Diabetes Mellitus; Eating; Fructose-Bisphosphatase; Glucose-6-Phosphatase; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Androstenedione; Blood Glucose; Body Mass Index; Female; Humans; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Retrospective Studies; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1999 |
The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Buserelin; Case-Control Studies; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Statistics, Nonparametric | 1999 |
Intrauterine growth retardation predisposes to insulin resistance but not to hyperandrogenism in young women.
Topics: Adolescent; Adult; Androstenedione; Birth Weight; Blood Glucose; Cohort Studies; Dehydroepiandrosterone Sulfate; Female; Fetal Growth Retardation; Glucose Tolerance Test; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Lipids; Sex Hormone-Binding Globulin; Testosterone | 1999 |
Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels.
Topics: Adult; Androstenedione; Blood Glucose; Cautery; Female; Humans; Hyperandrogenism; Infertility, Female; Insulin; Insulin Resistance; Laparoscopy; Lipids; Lipoproteins; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Testosterone | 1999 |
Adipocyte insulin action in hypogonadotrophic hypogonadism.
Topics: Adipocytes; Adult; Amenorrhea; Androstenedione; Blood; Case-Control Studies; Female; Follicle Stimulating Hormone; Glucose; Humans; Hypogonadism; Insulin; Insulin Resistance; Lipid Metabolism; Luteinizing Hormone | 2000 |
Induction of ovarian cystic follicles in sheep.
Topics: Androstenedione; Animals; Blood Glucose; Estradiol; Estrus Synchronization; Female; Follicle Stimulating Hormone; Growth Hormone; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Ovarian Cysts; Ovarian Follicle; Progesterone; Radioimmunoassay; Random Allocation; Sheep; Sheep Diseases; Testosterone; Ultrasonography | 2000 |
Impaired insulin action on granulosa-lutein cells in women with polycystic ovary syndrome and insulin resistance.
Topics: Androstenedione; Cells, Cultured; Corpus Luteum; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Granulosa Cells; Humans; Infertility, Female; Insulin; Insulin Resistance; Luteinizing Hormone; Ovulation Induction; Polycystic Ovary Syndrome; Progesterone; Receptor, Insulin; Recombinant Proteins; Sex Hormone-Binding Globulin; Testosterone | 2000 |
Role of the follistatin gene in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Adult; Androstenedione; Dehydroepiandrosterone Sulfate; Exons; Female; Follistatin; Genetic Variation; Glycoproteins; Humans; Insulin Resistance; Point Mutation; Polycystic Ovary Syndrome; Polymerase Chain Reaction; Polymorphism, Genetic; Sex Hormone-Binding Globulin; Testosterone; White People | 2001 |
The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome.
Topics: Androstenedione; Buserelin; Drug Resistance; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Recombinant Proteins; Sex Hormone-Binding Globulin; Sperm Injections, Intracytoplasmic; Testosterone; Treatment Outcome | 2001 |
Two hyperandrogenic adolescent girls with congenital portosystemic shunt.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenedione; Dehydroepiandrosterone; Female; Glucose Tolerance Test; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Magnetic Resonance Angiography; Polycystic Ovary Syndrome; Portal Vein; Vena Cava, Inferior | 2001 |
Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome.
Topics: Adolescent; Adult; Amenorrhea; Androstenedione; Bone Density; Case-Control Studies; Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 2001 |
Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Blood Glucose; Chorionic Gonadotropin; Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Obesity; Ovary; Polycystic Ovary Syndrome; Steroids; Testosterone | 2001 |
Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Adrenal Glands; Adult; Androstenedione; Body Composition; Body Constitution; Body Mass Index; Body Weight; Cholesterol, HDL; Fasting; Female; Humans; Insulin; Insulin Resistance; Lipoproteins; Lipoproteins, LDL; Nafarelin; Ovary; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 2002 |
Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Alleles; Androstenedione; Blood Glucose; Body Mass Index; Dehydroepiandrosterone Sulfate; Estradiol; Female; Hirsutism; Homozygote; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Minisatellite Repeats; Polycystic Ovary Syndrome; Polymorphism, Genetic; Sex Hormone-Binding Globulin; Spain; Testosterone | 2002 |
Endocrine consequences of premature pubarche in post-pubertal Caucasian girls.
Topics: Adolescent; Androgens; Androstenedione; Birth Weight; Case-Control Studies; Dehydroepiandrosterone Sulfate; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Prospective Studies; Puberty, Precocious; Statistics, Nonparametric; Testosterone | 2002 |
Primary amenorrhea associated with hirsutism, acanthosis nigricans, dermoid cysts of the ovaries and a new type of insulin resistance.
Topics: Acanthosis Nigricans; Adolescent; Amenorrhea; Androstenedione; Dermoid Cyst; Female; Hirsutism; Humans; Insulin Resistance; Ovarian Neoplasms; Ovary; Testosterone | 1978 |
Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.
Topics: Adult; Androstenedione; Body Mass Index; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Testosterone | 1992 |
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
Topics: Adult; Androstane-3,17-diol; Androstenedione; Diazoxide; Estradiol; Estrone; Female; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Insulin; Insulin Resistance; Leuprolide; Obesity; Polycystic Ovary Syndrome; Progesterone; Sex Hormone-Binding Globulin; Testosterone | 1991 |
A syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans associated with polycystic ovary syndrome: clinical and laboratory features.
Topics: Acanthosis Nigricans; Adolescent; Androgens; Androstenedione; Anovulation; Blood Glucose; Female; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Insulin; Insulin Resistance; Japan; Menstruation Disturbances; Polycystic Ovary Syndrome; Testosterone | 1990 |
Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
Topics: Adult; Androgens; Androstenedione; Blood Glucose; Dehydroepiandrosterone; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Kinetics; Obesity; Polycystic Ovary Syndrome; Testosterone; Tolbutamide | 1990 |
Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history.
Topics: Acanthosis Nigricans; Adolescent; Androstenedione; Body Weight; Child; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin Resistance; Luteinizing Hormone; Male; Menarche; Obesity; Pedigree; Syndrome; Testosterone | 1985 |
Evidence for insulin resistance in nonobese patients with polycystic ovarian disease.
Topics: Adult; Androstenedione; Blood Glucose; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Erythrocytes; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; India; Insulin; Insulin Resistance; Luteinizing Hormone; Polycystic Ovary Syndrome; Receptor, Insulin; South Africa; Testosterone | 1987 |
Familial acanthosis nigricans. A longitudinal study.
Topics: Acanthosis Nigricans; Adolescent; Androstenedione; Blood Glucose; Contraceptives, Oral; Female; Humans; Insulin; Insulin Resistance; Longitudinal Studies; Syndrome; Testosterone | 1987 |
Effect of chronically elevated androgen or estrogen on the glucose tolerance test and insulin response in female rhesus monkeys.
Topics: Androstenedione; Animals; C-Peptide; Estradiol; Estrone; Female; Glucose Tolerance Test; Insulin; Insulin Resistance; Macaca mulatta; Testosterone; Time Factors | 1987 |
Hyperandrogenism, insulin resistance, acanthosis nigricans, and systemic lupus erythematosis associated with insulin receptor antibodies.
Topics: Acanthosis Nigricans; Adipose Tissue; Adolescent; Androstenedione; Blood Glucose; Female; Hirsutism; Humans; Insulin Resistance; Lupus Erythematosus, Systemic; Receptor, Insulin; Testosterone | 1988 |
Hyperinsulinemia in hyperthecosis of the ovaries.
Topics: Androstenedione; Dihydrotestosterone; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Ovarian Diseases; Ovary; Polycystic Ovary Syndrome; Syndrome; Testosterone; Theca Cells; Virilism | 1986 |
Hyperinsulinemia and hyperandrogenemia: in vivo androgen response to insulin infusion.
Topics: Acanthosis Nigricans; Adolescent; Adult; Androgens; Androstenedione; Female; Hirsutism; Humans; Hydrocortisone; Hyperinsulinism; Insulin; Insulin Resistance; Male; Obesity | 1987 |